ARTHROSAMID INJECTION
Arthrosamid Injection in Collingwood: A New Option for Lasting Relief from Osteoarthritis
Osteoarthritis breaks down joint cartilage over time, leading to pain that doesn’t just flare during a workout – it lingers through everyday life. For many in Collingwood, it means waking with stiff knees, struggling to squat, climb stairs, or even take a long walk. Common symptoms like inflammation, decreased mobility, and joint stiffness don’t just affect joints – they limit independence, disrupt routines, and erode overall well-being. Hundreds of thousands of Canadians face this degenerative condition daily, and traditional treatments often fall short of delivering lasting comfort. Enter Arthrosamid injection – Collingwood’s newest breakthrough in managing osteoarthritis pain.
Where Conventional Solutions End, Arthrosamid Begins
Arthrosamid is changing the expectations for injection therapy. Unlike HA or steroids, it’s not a temporary filler or a short-lived anti-inflammatory fix. This polyacrylamide hydrogel forms an integrated cushion inside the knee, creating a long-lasting effect without the need for repeat injections every few months.
For individuals in Collingwood searching for a new direction in osteoarthritis management, Arthrosamid introduces a science-backed therapeutic shift- redefining longevity, durability, and joint support from within.
What is Arthrosamid?
Arthrosamid is a non-biodegradable polyacrylamide hydrogel injection designed for the treatment of knee osteoarthritis (OA). Unlike traditional injections, it doesn’t just manage inflammation temporarily- it transforms the joint environment. This single-dose, intra-articular therapy creates a durable cushioning effect within the knee, improving mobility and reducing pain over the long term.
Health Canada has approved Arthrosamid as a Class III medical device. Developed in Denmark, and tested across European centres in double-blind clinical trials, this hydrogel has been used in more than 20,000 knees globally.
Composition: Polyacrylamide Hydrogel
The active component in Arthrosamid is non-absorbable polyacrylamide hydrogel, made of 2.5% cross-linked polyacrylamide and 97.5% water. This creates a highly stable, viscoelastic substance that integrates safely into the knee joint capsule. Once injected, the hydrogel does not degrade like corticosteroids or hyaluronic acid do, maintaining its mechanical integrity over the years.
How It Works
After a single injection into the synovial cavity of the knee, Arthrosamid permanently supplements the joint’s buffer system. The hydrogel binds with the synovial membrane, forming a protective and lubricating layer that absorbs mechanical shock and enhances joint biomechanics. This rehydration of the intra-articular space reduces nociceptive pain signals and friction between cartilage surfaces, creating a smoother glide with motion.
The effect is not temporary. European follow-up studies, including the ROSE study published in the journal Cartilage (2021), confirm sustained improvement in pain relief and function beyond 2 years in patients receiving a single treatment.
No Operating Rooms. No General Anesthesia. No Hospital Stay.
Patients receive Arthrosamid treatment in a clinical setting without the risks or recovery burden of surgery. The injection is performed under local anesthetic using image guidance for precise delivery to the joint space. The entire procedure is outpatient-based, with most patients walking out of the clinic within an hour.
What Happens When the Needle Hits the Joint
Arthrosamid works right where osteoarthritis causes damage – inside the knee joint. Administered as a single injection, it’s delivered directly into the intra-articular space of the affected knee. The procedure takes place in a clinical setting using ultrasound or image guidance to ensure precise placement of the hydrogel-based product.
Bonding with the Synovial Membrane
Once injected, Arthrosamid interacts with the synovial lining of the joint – this is where the transformation begins. Unlike traditional injectables that merely lubricate, the polyacrylamide hydrogel chemically integrates with the synovium. This bonding process allows it to create a resilient, soft-layered cushion within the joint space.
Who benefits most from Arthrosamid injections?
Not every knee pain case leads to the operating room. Arthrosamid is designed for adults with knee osteoarthritis who haven’t responded to conventional treatments like physiotherapy, NSAIDs, or hyaluronic acid injections. It’s especially suited to individuals seeking to avoid the risks, long healing periods, and irreversible changes associated with total knee replacement.
Patients often turn to surgery when daily activities—climbing stairs, walking a few blocks, or even standing—become difficult. Arthrosamid offers a detour. Rather than replacing the joint, the injection enhances its function, reduces pain, and delays or removes the need for invasive surgical procedures.